RDY Pretax Profit Margin from 2010 to 2024

RDY Stock  USD 14.08  0.06  0.42%   
Dr Reddys Pretax Profit Margin yearly trend continues to be fairly stable with very little volatility. Pretax Profit Margin is likely to outpace its year average in 2024. During the period from 2010 to 2024, Dr Reddys Pretax Profit Margin regression line of annual values had r-squared of  0.17 and arithmetic mean of  0.17. View All Fundamentals
 
Pretax Profit Margin  
First Reported
2010-12-31
Previous Quarter
0.25744724
Current Value
0.27
Quarterly Volatility
0.05720374
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 1.8 B, Total Revenue of 293.1 B or Gross Profit of 171.8 B, as well as many indicators such as Price To Sales Ratio of 3.91, Dividend Yield of 0.0061 or PTB Ratio of 3.89. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.
  
Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Pretax Profit Margin Growth Pattern

Below is the plot of the Pretax Profit Margin of Dr Reddys Laboratories over the last few years. It is Dr Reddys' Pretax Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.
Pretax Profit Margin10 Years Trend
Slightly volatile
   Pretax Profit Margin   
       Timeline  

RDY Pretax Profit Margin Regression Statistics

Arithmetic Mean0.17
Geometric Mean0.16
Coefficient Of Variation33.41
Mean Deviation0.05
Median0.18
Standard Deviation0.06
Sample Variance0
Range0.1731
R-Value0.41
Mean Square Error0
R-Squared0.17
Significance0.13
Slope0.01
Total Sum of Squares0.05

RDY Pretax Profit Margin History

2024 0.27
2023 0.26
2022 0.25
2018 0.15
2016 0.1
2015 0.18

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Pretax Profit Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.26  0.27 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.